Source: International Congress 2016 – Pulmonary arterial hypertension: future therapeutic approaches
Disease area: Pulmonary vascular diseases



Rating:

Share or cite this content

Citations should be made in the following way:
Paul Upton (Cambridge, United Kingdom). Targeting BMPR-II in pulmonary arterial hypertension. International Congress 2016 – Pulmonary arterial hypertension: future therapeutic approaches

Member's Comments

No comment yet.

Related content which might interest you: Endothelial control of BMPR2 signalling in experimental shunt-induced pulmonary arterial hypertension Source: Research Seminar 2005 - Pulmonary Circulation: Molecular Determinants of Pulmonary Vascular Remodelling Year: 2005 Roundabout (Robo) receptors on pulmonary artery endothelial cells: Implications for pulmonary arterial hypertension Source: International Congress 2016 – The nature of pulmonary hypertension Year: 2016 Pulmonary arterial hypertension Source: ISSN=ISSN 1810-6838, ISBN=, page=397 Year: 2007 Pulmonary arterial hypertension Source: Eur Respir Monogr 2014; 66: 232-246 Year: 2014 Pulmonary arterial hypertension Source: ISSN=ISSN 1810-6838, ISBN=, page=126 Year: 2005 Pulmonary arterial hypertension Source: Breathe 2010; 6: 377-380 Year: 2010 Pulmonary arterial hypertension Source: Eur Respir Monogr 2013; 62: 70-84 Year: 2013 Pulmonary arterial hypertension Source: International Congress 2018 – State of the art session: Pulmonary vascular diseases Year: 2018 Relationship of BMPR2 mutations and vasoreactivity in pulmonary arterial hypertension Source: Research Seminar 2005 - Pulmonary Circulation: Molecular Determinants of Pulmonary Vascular Remodelling Year: 2005 Involvement of CFTR in the pathogenesis of pulmonary arterial hypertension Source: Eur Respir J, 58 (5) 2000653; 10.1183/13993003.00653-2020 Year: 2021 Endothelium in pulmonary arterial hypertension Source: Annual Congress 2007 - Role of the endothelium in pulmonary function and disease Year: 2007 Bosentan and improved pulmonary endothelial function in pulmonary arterial hypertension Source: Eur Respir J 2010; 36: 1483-1485 Year: 2010 Endothelial cells in the pathogenesis of pulmonary arterial hypertension Source: Eur Respir J, 58 (3) 2003957; 10.1183/13993003.03957-2020 Year: 2021 Inflammatory mediators contribute to pulmonary arterial cell dysfunction in a pulmonary arterial hypertension patient with BMPR2 mutation Source: Annual Congress 2013 –Pulmonary circulation: clinical pulmonary hypertension I Year: 2013 Apelin improves cardiac output in patients with pulmonary arterial hypertension Source: International Congress 2015 – Pulmonary hypertension: novel clinical insights Year: 2015 Beyond arterial remodelling: pulmonary venous and cardiac involvement in patients with systemic sclerosis-associated pulmonary arterial hypertension Source: Eur Respir J 2010; 35: 6-8 Year: 2010 Peripheral arterial stiffness and endothelial dysfunction in pulmonary arterial hypertension Source: International Congress 2015 – Pulmonary hypertension: the right ventricle and its load Year: 2015 Targeting cell motility in pulmonary arterial hypertension Source: Eur Respir J 2014; 43: 531-544 Year: 2013 Systemic consequences of pulmonary arterial hypertension Source: International Congress 2019 – State of the art session: Pulmonary vascular diseases Year: 2019 The genetics of pulmonary arterial hypertension Source: Research Seminar 2005 - Pulmonary Circulation: Molecular Determinants of Pulmonary Vascular Remodelling Year: 2005